These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 25881507)
41. Lgr5 is a potential prognostic marker in patients with cervical carcinoma. Sun B; Ye X; Li Y; Zhang W Int J Clin Exp Pathol; 2015; 8(2):1783-9. PubMed ID: 25973068 [TBL] [Abstract][Full Text] [Related]
42. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry. Yang W; Wang Y; Wang W; Chen Z; Bai G Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529 [TBL] [Abstract][Full Text] [Related]
43. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer. Lu C; Wang X; Zhu H; Feng J; Ni S; Huang J Oncotarget; 2015 Sep; 6(28):24912-21. PubMed ID: 26305508 [TBL] [Abstract][Full Text] [Related]
44. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer. You Q; Guo H; Xu D Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059 [TBL] [Abstract][Full Text] [Related]
45. Expression and significance of myeloid differentiation factor 88 in non-small cell lung carcinoma and normal paracancerous tissues. Zhu J; Li Q; He J; Ma K Genet Mol Res; 2015 Nov; 14(4):14239-45. PubMed ID: 26600481 [TBL] [Abstract][Full Text] [Related]
46. Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma. Vigouroux C; Casse JM; Battaglia-Hsu SF; Brochin L; Luc A; Paris C; Lacomme S; Gueant JL; Vignaud JM; Gauchotte G Lung Cancer; 2015 Aug; 89(2):189-96. PubMed ID: 26013954 [TBL] [Abstract][Full Text] [Related]
47. Combined expression of aldehyde dehydrogenase 1A1 and β-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment. Sun M; Zhao H; Xiao Q; Yu Z; Song Z; Yao W; Tang H; Guan S; Jin F; Wei M Oncol Rep; 2015 Dec; 34(6):3163-73. PubMed ID: 26398662 [TBL] [Abstract][Full Text] [Related]
48. Garcinol from Garcinia indica Downregulates Cancer Stem-like Cell Biomarker ALDH1A1 in Nonsmall Cell Lung Cancer A549 Cells through DDIT3 Activation. Wang J; Wang L; Ho CT; Zhang K; Liu Q; Zhao H J Agric Food Chem; 2017 May; 65(18):3675-3683. PubMed ID: 28420235 [TBL] [Abstract][Full Text] [Related]
49. High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer. Cao X; Tang Z; Huang F; Jin Q; Zhou X; Shi J Oncotarget; 2017 Feb; 8(8):12812-12819. PubMed ID: 28086212 [TBL] [Abstract][Full Text] [Related]
50. [Expression of endoglin in human non-small cell lung cancer and its clinical significance]. Li M; Lu S; Liu X; Zhao J; Zhang H; Ling C Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):581-4. PubMed ID: 23746240 [TBL] [Abstract][Full Text] [Related]
51. Co-expression of immunoglobulin-like transcript 4 and angiopoietin-like proteins in human non-small cell lung cancer. Wang L; Geng T; Guo X; Liu J; Zhang P; Yang D; Li J; Yu S; Sun Y Mol Med Rep; 2015 Apr; 11(4):2789-96. PubMed ID: 25482926 [TBL] [Abstract][Full Text] [Related]
52. TRIM66 expression in non-small cell lung cancer: A new predictor of prognosis. Ma Y; Dai HY; Zhang F; Zhao D Cancer Biomark; 2017 Sep; 20(3):309-315. PubMed ID: 28946563 [TBL] [Abstract][Full Text] [Related]
53. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer]. Liu HX; Xing LX; Wang HB; Yang JQ; Sun YM Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586 [TBL] [Abstract][Full Text] [Related]
54. Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small-cell lung cancer progression and patients' overall survival. Kuang BH; Zhang MQ; Xu LH; Hu LJ; Wang HB; Zhao WF; Du Y; Zhang X Br J Cancer; 2013 Sep; 109(5):1252-63. PubMed ID: 23922106 [TBL] [Abstract][Full Text] [Related]
55. [Expression and clinical significance of IL-33 in patients with non-small cell lung cancer]. Feng Y; Zhu Y; Luo G; Wang Z; Yu P; Zheng L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):808-11. PubMed ID: 27371849 [TBL] [Abstract][Full Text] [Related]
56. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance. He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002 [TBL] [Abstract][Full Text] [Related]
57. Matrix-remodeling associated 5 as a novel tissue biomarker predicts poor prognosis in non-small cell lung cancers. He Y; Chen X; Liu H; Xiao H; Kwapong WR; Mei J Cancer Biomark; 2015; 15(5):645-51. PubMed ID: 26406953 [TBL] [Abstract][Full Text] [Related]
58. Expression of p130cas, E-cadherin and β-catenin and their correlation with clinicopathological parameters in non-small cell lung cancer: p130cas over-expression predicts poor prognosis. Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Han Y; Liu Y; Wang E Folia Histochem Cytobiol; 2012 Oct; 50(3):392-7. PubMed ID: 23042269 [TBL] [Abstract][Full Text] [Related]
59. Activated STAT3 correlates with prognosis of non-small cell lung cancer and indicates new anticancer strategies. Yu Y; Zhao Q; Wang Z; Liu XY Cancer Chemother Pharmacol; 2015 May; 75(5):917-22. PubMed ID: 25735252 [TBL] [Abstract][Full Text] [Related]
60. Clinical significance of nucleostemin and proliferating cell nuclear antigen protein expression in non-small cell lung cancer. Li X; Liu X; Cui D; Wu X; Qian R J BUON; 2015; 20(4):1088-93. PubMed ID: 26416061 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]